mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.001 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.002 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |